FTO expression was significantly upregulated in patients with obesity (fold-change: 5.8 vs. 1.0, p < 0.001), showing a parallel elevation with adiponectin and BMI at the group level. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.